Armonización facial cambios imprevistos en tiempos de pandemia

Abstract

1. Dhanda AK, Leverant E, Leshchuk K, Paskhover B. A Google Trends Analysis of Facial Plastic Surgery Interest During the COVID-19 Pandemic. Aesthetic Plast Surg. 2020 Aug; 44(4):1378-1380. doi: 10.1007/s00266-020-01903-y. 2. Pang R, Wei Z, Liu W, Chen Z, Cheng X, Zhang H, Li G, Liu L. Influence of the pandemic dissemination of COVID-19 on facial rejuvenation: A survey of Twitter. J Cosmet Dermatol. 2020 Nov; 19(11):2778-2784. doi: 10.1111/jocd.13688. 3. Ors S. High Superficial Musculoaponeurotic System Lamellar Facelift Under Local Anesthesia. J Craniofac Surg. 2021 Jan 25. doi: 10.1097/SCS.0000000000007466. 4. Bertossi D, Mohsahebi A, Philipp-Dormston WD, Heidenrich I, Pirayesh A, D'Souza A, Saleh H, Yavuzer R, Fakih N, Vent J, Rahman E, Kapoor KM. Safety guidelines for nonsurgical facial procedures during COVID-19 outbreak. J Cosmet Dermatol. 2020 Aug; 19(8):1829-1837. doi: 10.1111/jocd.13530. 5. Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020 Jun; 76:14-20. doi: 10.1016/j.ejim.2020.04.037 6. Munavalli GG, Guthridge R, Knutsen-Larson S, Brodsky A, Matthew E, Landau M. “COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment. Arch Dermatol Res. 2021 Feb 9:1-15. doi: 10.1007/s00403-021-02190-6. 7. Munavalli GG, Knutsen-Larson S, Lupo MP, Geronemus RG. Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II-induced cutaneous inflammation. JAAD Case Rep. 2021 Apr; 10:63-68. doi: 10.1016/j.jdcr.2021.02.018. 8. El-Tallawy SN, Nalamasu R, Pergolizzi JV, Gharibo C. Pain Management During the COVID-19 Pandemic. Pain Ther. 2020 Dec;9(2):453-466. doi: 10.1007/s40122-020-00190-4. 9. Akdogan N. Severe hyperalgesia and pain during botulinum toxin injection avoiding application in a patient 1 week after COVID-19 infection. J Cosmet Dermatol. 2021 Mar; 20(3):755-756. doi: 10.1111/jocd.13897.